These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12031670)

  • 1. Crystal structure of a squalene cyclase in complex with the potential anticholesteremic drug Ro48-8071.
    Lenhart A; Weihofen WA; Pleschke AE; Schulz GE
    Chem Biol; 2002 May; 9(5):639-45. PubMed ID: 12031670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding site for an inhibitor of squalene:hopene cyclase determined using photoaffinity labeling and molecular modeling.
    Dang T; Abe I; Zheng YF; Prestwich GD
    Chem Biol; 1999 Jun; 6(6):333-41. PubMed ID: 10375539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoaffinity labeling of oxidosqualene cyclase and squalene cyclase by a benzophenone-containing inhibitor.
    Abe I; Zheng YF; Prestwich GD
    Biochemistry; 1998 Apr; 37(17):5779-84. PubMed ID: 9558310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase.
    Thoma R; Schulz-Gasch T; D'Arcy B; Benz J; Aebi J; Dehmlow H; Hennig M; Stihle M; Ruf A
    Nature; 2004 Nov; 432(7013):118-22. PubMed ID: 15525992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis of squalene-hopene cyclase: altered substrate specificity and product distribution.
    Dang T; Prestwich GD
    Chem Biol; 2000 Aug; 7(8):643-9. PubMed ID: 11048954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene-hopene cyclase.
    Lenhart A; Reinert DJ; Aebi JD; Dehmlow H; Morand OH; Schulz GE
    J Med Chem; 2003 May; 46(11):2083-92. PubMed ID: 12747780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbelliferone aminoalkyl derivatives, a new class of squalene-hopene cyclase inhibitors.
    Cravotto G; Balliano G; Tagliapietra S; Palmisano G; Penoni A
    Eur J Med Chem; 2004 Nov; 39(11):917-24. PubMed ID: 15501540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational study of the mechanism and the relative free energies of binding of anticholesteremic inhibitors to squalene-hopene cyclase.
    Schwab F; van Gunsteren WF; Zagrovic B
    Biochemistry; 2008 Mar; 47(9):2945-51. PubMed ID: 18247576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of squalene to the pentacarbocyclic hopene.
    Reinert DJ; Balliano G; Schulz GE
    Chem Biol; 2004 Jan; 11(1):121-6. PubMed ID: 15113001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationally designed inhibitors as tools for comparing the mechanism of squalene-hopene cyclase with oxidosqualene cyclase.
    Viola F; Ceruti M; Cattel L; Milla P; Poralla K; Balliano G
    Lipids; 2000 Mar; 35(3):297-303. PubMed ID: 10783007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design strategies of oxidosqualene cyclase inhibitors: Targeting the sterol biosynthetic pathway.
    Rabelo VW; Romeiro NC; Abreu PA
    J Steroid Biochem Mol Biol; 2017 Jul; 171():305-317. PubMed ID: 28479228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjugated methyl sulfide and phenyl sulfide derivatives of oxidosqualene as inhibitors of oxidosqualene and squalene-hopene cyclases.
    Rocco F; Bosso SO; Viola F; Milla P; Roma G; Grossi G; Ceruti M
    Lipids; 2003 Mar; 38(3):201-7. PubMed ID: 12784859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel squalene-hopene cyclase inhibitors derived from hydroxycoumarins and hydroxyacetophenones.
    Cravotto G; Balliano G; Tagliapietra S; Oliaro-Bosso S; Nano GM
    Chem Pharm Bull (Tokyo); 2004 Oct; 52(10):1171-4. PubMed ID: 15467228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of a squalene cyclase.
    Wendt KU; Poralla K; Schulz GE
    Science; 1997 Sep; 277(5333):1811-5. PubMed ID: 9295270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition kinetics and affinity labeling of bacterial squalene:hopene cyclase by thia-substituted analogues of 2, 3-oxidosqualene.
    Zheng YF; Abe I; Prestwich GD
    Biochemistry; 1998 Apr; 37(17):5981-7. PubMed ID: 9558334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesyloxycoumarins, a new class of squalene-hopene cyclase inhibitors.
    Cravotto G; Balliano G; Robaldo B; Oliaro-Bosso S; Chimichi S; Boccalini M
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1931-4. PubMed ID: 15050630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification, kinetics, inhibitors and CD for recombinant β-amyrin synthase from Euphorbia tirucalli L and functional analysis of the DCTA motif, which is highly conserved among oxidosqualene cyclases.
    Ito R; Masukawa Y; Hoshino T
    FEBS J; 2013 Mar; 280(5):1267-80. PubMed ID: 23294602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squalene-hopene cyclase: final deprotonation reaction, conformational analysis for the cyclization of (3R,S)-2,3-oxidosqualene and further evidence for the requirement of an isopropylidene moiety both for initiation of the polycyclization cascade and for the formation of the 5-membered E-ring.
    Hoshino T; Nakano S; Kondo T; Sato T; Miyoshi A
    Org Biomol Chem; 2004 May; 2(10):1456-70. PubMed ID: 15136801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the channel constriction allowing the access of the substrate to the active site of yeast oxidosqualene cyclase.
    Oliaro-Bosso S; Caron G; Taramino S; Ermondi G; Viola F; Balliano G
    PLoS One; 2011; 6(7):e22134. PubMed ID: 21811565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, tandem mass characterization, and inhibition studies of oxidosqualene-lanosterol cyclase enzyme from bovine liver.
    Wu TK; Huang CY; Ko CY; Chang CH; Chen YJ; Liao HK
    Arch Biochem Biophys; 2004 Jan; 421(1):42-53. PubMed ID: 14678783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.